Corindus Vascular Robotics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

corindus.com

Founded Year

2002

Stage

Acq - P2P | Acquired

Total Raised

$18.1M

Valuation

$0000 

About Corindus Vascular Robotics

Corindus Vascular Robotics (NYSEAMERICAN: CVRS) designs, manufactures, and sells precision vascular robotic-assisted systems for use in interventional vascular procedures.

Corindus Vascular Robotics Headquarter Location

309 Waverley Oaks Road Suite 105

Waltham, Massachusetts, 02452,

United States

508-653-3335

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Corindus Vascular Robotics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Corindus Vascular Robotics in 3 CB Insights research briefs, most recently on Oct 5, 2021.

Expert Collections containing Corindus Vascular Robotics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Corindus Vascular Robotics is included in 3 Expert Collections, including Robotics.

R

Robotics

1,801 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.

D

Digital Health

12,999 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Corindus Vascular Robotics Patents

Corindus Vascular Robotics has filed 100 patents.

The 3 most popular patent topics include:

  • Interventional radiology
  • Vascular diseases
  • Catheters
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/13/2016

4/19/2022

Medical imaging, Video formats, Medical equipment, Image processing, Catheters

Grant

Application Date

12/13/2016

Grant Date

4/19/2022

Title

Related Topics

Medical imaging, Video formats, Medical equipment, Image processing, Catheters

Status

Grant

Latest Corindus Vascular Robotics News

Corindus, A Siemens Healthineers Company, to Showcase CorPath GRX Robotic System at EuroPCR 2022

May 13, 2022

Robotic-assisted PCI will be prominently featured at the world-leading course in interventional cardiovascular medicine Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced that it will showcase the CorPath GRX System, the first and only FDA-cleared and CE marked medical device for robotic-assisted coronary interventions, at EuroPCR 2022 through live cases, scientific presentations, and multiple Siemens Healthineers-sponsored symposia. One of the sessions, featuring Professor Dariusz Dudek from the Institute of Cardiology at Jagiellonian University Medical College, will include new clinical data from the NAVIGATE study, a novel, post-market study which evaluated CorPath GRX technIQ™ automated movements in PCI. EuroPCR is returning to in-person attendance in Paris, France, from May 17-22, 2022. “EuroPCR is a world-leading course in interventional cardiology, and we are pleased to see the growing enthusiasm for robotic technology, as evidenced by the program” The course is scheduled to open with a live broadcast of a robotic-assisted PCI case performed at Clinique Pasteur in Toulouse, France, during which the clinical team will utilize a CorPath GRX System. The same day, Siemens Healthineers will host an educational symposium on imaging and robotics, “Personalized coronary intervention with CT-guided robotic-assisted PCI.” The session will help attendees understand how coronary CT angiography can bring additional value in the diagnosis of coronary artery disease, pre-procedural planning, and procedural guidance of coronary interventions. It will also include a case demonstration featuring CT angiography and robotic-assisted PCI. “EuroPCR is a world-leading course in interventional cardiology, and we are pleased to see the growing enthusiasm for robotic technology, as evidenced by the program,” said Wayne Markowitz, Worldwide Executive Vice President and Business Head of Corindus. “We’re especially excited that Professor Dudek will share new clinical data from the NAVIGATE study. Sharing these initial results with the clinical community marks another step toward continuing our research on procedural automation.” Professor Dudek will present the data as part of the “Innovations in simulation-based training, procedural planning, monitoring and robotic PCI” session. Siemens Healthineers will also host a second educational symposium, “Robotic-assisted intervention: latest clinical insights and applications for complex PCI,” featuring interventional cardiologists Dariusz Dudek, Jean Fajadet, Eric Wyffels, and Constantin von zur Mühlen. It will provide an overview of CorPath GRX and technIQ Smart Procedural Automation, as well as robotic training program best practices, novel training techniques using 3D heart flow models, and additional insights on the clinical data from the NAVIGATE study. “I am pleased to share my findings from the NAVIGATE Study, which indicates promising results for procedural automation in robotic-assisted PCI,” Professor Dudek said. “Coronary artery disease is one of the leading causes of death globally, and incorporating new technological advancements, like robotics and automation, can advance precision and safety for both patients and practitioners. I look forward to sharing my experience with CorPath GRX and the benefits the system has to offer at this year’s EuroPCR course.”

  • When was Corindus Vascular Robotics founded?

    Corindus Vascular Robotics was founded in 2002.

  • Where is Corindus Vascular Robotics's headquarters?

    Corindus Vascular Robotics's headquarters is located at 309 Waverley Oaks Road, Waltham.

  • What is Corindus Vascular Robotics's latest funding round?

    Corindus Vascular Robotics's latest funding round is Acq - P2P.

  • How much did Corindus Vascular Robotics raise?

    Corindus Vascular Robotics raised a total of $18.1M.

  • Who are the investors of Corindus Vascular Robotics?

    Investors of Corindus Vascular Robotics include Siemens Healthineers, Technion Seed and HealthCor Management.

  • Who are Corindus Vascular Robotics's competitors?

    Competitors of Corindus Vascular Robotics include ACTIV Surgical, Vicarious Surgical, Quantum Surgical, CMR Surgical, Stereotaxis and 9 more.

You May Also Like

M
Medrobotics

Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.

CMR Surgical Logo
CMR Surgical

CMR Surgical is a surgical robotics company developing universal robotic systems for minimal access surgery. The company's vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically.

A
ACTIV Surgical

Activ is a developer of software to augment surgeons. It develops an AI/ML platform called ActivEdge, which is designed to provide real-time intelligence and visualization to surgeons. The company was founded in 2017 and is based in Boston, Massachusetts.

I
Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.

B
Bionaut Labs

Bionaut Labs is a biotech company that designs and manufactures intra- tissue navigation using Bionaut nano/micro robots operating inside the body. The company is based in Los Angeles, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.